Portola Valley, CA, United States of America

George Tidmarsh

This inventor holds 17 USPTO granted patents and 19 published patent applications, plus 2 CIPO patents and 3 EPO patents, primarily in Cancer Treatment. Top assignees: Threshold Pharmaceuticals, Inc., Horizon Pharma USA, Inc., La Jolla Pharma, LLC. Active years: 2005-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: George Tidmarsh. Retrieved from https://idiyas.com/inventor/george-tidmarsh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 17 

% Patents Active = 52.9

 

 

Average Co-Inventor Count = 1.5

ph-index = 7

Forward Citations = 199(Granted Patents)


Company Filing History:


Years Active: 2005-2023

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Angiotensin II
Hypotension
Renal Failure
Anti-Cancer Therapies
Famotidine
Ibuprofen
Neoplastic Agents
Cancer Imaging
Benign Prostatic Hyperplasia
2-Deoxyglucose
17 patents (USPTO):Explore Patents

Title: The Innovative Mind of George Tidmarsh

Introduction: George Tidmarsh, a brilliant inventor hailing from Portola Valley, CA, is a pioneering female figure in the world of innovation.

Latest Patents: George Tidmarsh's latest patents include groundbreaking technologies in the field of biotechnology, with a focus on personalized medicine and drug development.

Career Highlights: Throughout her illustrious career, George Tidmarsh has been at the forefront of cutting-edge research, leading to the development of life-changing inventions that have revolutionized the healthcare industry.

Collaborations: George Tidmarsh has collaborated with top research institutions, pharmaceutical companies, and universities to further advance her innovative ideas and bring them to fruition.

Conclusion: George Tidmarsh's dedication to innovation and her relentless pursuit of scientific excellence continue to inspire future generations of inventors and researchers.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…